| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_842a4ea01386db06b942dafadd3b5cce |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2011-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_662d192b71b02ec622d8898ab8760070
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3ed433888f5a7cc71d6646ef82f1faf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4139cbc4fda4a9c980eb86fc9cda644c |
| publicationDate |
2011-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2011236018-A1 |
| titleOfInvention |
Method for carrying therapeutic substances into cells |
| abstract |
Nanoparticles when used in a method for prophylaxis and/or treatment of a cancerous or tumor disease, wherein the nanoparticles are administered with an anti-cancer 5 drug so that the nanoparticles and the anti-cancer drug are present in the patient body at the same time, and wherein the nanoparticles have a positive surface charge, and the nanoparticles and the anti-cancer drug are administered separately. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111454274-A |
| priorityDate |
2005-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |